Mather Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$30.2K Buy
118
+66
+127% +$16.2K ﹤0.01% 1320
2026
Q2
$9.7K Buy
52
+29
+126% +$5.33K ﹤0.01% 1505
2026
Q1
$4.34K Buy
+23
New +$4.85K ﹤0.01% 1597
2025
Q4
– Sell
-23
Closed -$4.67K – 1548
2025
Q3
$4.67K Buy
+23
New +$4.08K ﹤0.01% 1405
2025
Q2
– Sell
-23
Closed -$3.09K – 1613
2025
Q1
$3.09K Hold
23
– – ﹤0.01% 1498
2024
Q4
$2.9K Hold
23
– – ﹤0.01% 1473
2024
Q3
$3.82K Buy
+23
New +$3.48K ﹤0.01% 1351

Other funds holding THC

Mather Group's THC Position: Q3 2026 in Review

Mather Group increased its Tenet Healthcare (THC) stake by 127% in Q3 2026, buying an estimated $16.2K and bringing the position to 118 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1320.

Mather Group first reported a position in THC in Q3 2024 and has held it in 7 quarters since. 142 funds tracked by Wall St. Rank hold THC as of Q3 2026.

  • Mather Group held 118 shares of Tenet Healthcare worth $30.2K as of Q3 2026.
  • Mather Group bought 66 Tenet Healthcare shares in Q3 2026, an estimated $16.2K.
  • Tenet Healthcare made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1320 holding.
  • Mather Group first reported a position in Tenet Healthcare in Q3 2024 and has held it in 7 quarters since.
  • 142 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.